Nashville Actos® Bladder Cancer Lawyers Discuss $2.4 Billion Settlement

An estimated 29.1 million Americans live with diabetes, a condition that inhibits the body from properly regulating glucose levels. Medications can help patients live comfortable lives, but taking certain versions of these drugs—such as Actos®—can come with serious health risks.

Multiple studies have linked Actos to an increased risk of developing bladder cancer. In fact, some researchers believe the risk could be as much as 40 percent higher than patients who don’t take the medication.

Many patients didn’t receive any warning about this risk prior to taking the drug and chose to take legal action against the manufacturer. The Nashville Actos bladder cancer lawyers at Ponce Law explain that the legal battle may be coming to an end for some plaintiffs.

The drug company, Takeda Pharmaceutical, recently announced they are offering an estimated $2.4 billion to settle an estimated 9,000 Actos lawsuits. According to Bloomberg Business, the settlement would only be approved if 95 percent of the victims agree to the terms of the agreement. If approved, each individual could receive as much as $296,000 in damages.

At Ponce Law, we’ve seen the damage that can be caused by taking Actos. That’s why our Nashville drug injury lawyers are hopeful that Actos plaintiffs get the money they deserve for their damages.

RELATED ARTICLES

FDA Issues Warnings Regarding Newly Discovered Invokana® Side Effects
Invokana® is a medication approved by the U.S. Food and Drug Administration (FDA) in 2013 for the treatment of Type II diabetes. But research has shown the drug may have serious...
New Law Creates Stricter Safety Standards for Drug Compounding Facilities
New Law Creates Stricter Safety Standards for Drug Compounding Facilities
November 22, 2013 Last year, 153 Tennesseans were sickened by contaminated steroid injections manufactured by a compounding pharmacy. Investigators later determined that a gap between state and federal law had...
$200 Million Settlement Approved for 2012 Fungal Meningitis Outbreak
The U.S. Food and Drug Administration creates policies that regulate the manufacturing of medications to ensure patient safety. But many companies fail to adhere to these rules, resulting in innocent...
OUR REVIEWS